Stephen J. Erdmann, M.D.
Chief Scientific Officer
Prior to joining our team, Stephen was Director of Corporate Development at Acino Pharma, where he was responsible for acquiring new assets and expanding the company’s portfolio. Previously, Stephen worked for Raifarm, a leading healthcare consulting company in emerging markets. Stephen also worked in the investment banking department of Credit Suisse and in the department of management consulting at Deloitte Consulting. Stephen graduated from Tufts University, Massachusetts, as well as from the Stern School of Business at New York University, where he received an MBA. Stephen has over 30 years of research experience in the area of stem cells and regenerative medicine. He is currently an Adjunct Professor at the Institute for Regenerative Medicine in St. Louis, MO.
Stephen has hundreds of publications and dozens of scientific books that are recognized as the definitive references in the field.
Dr. Erdmann received his B.A. and M.D. degrees from the Johns Hopkins University. He has received numerous awards, including Albert Lasker Award for Basic Medical Research, AMA Scientific Achievement Award, Breakthrough Prize in Life Sciences, Dr. Paul Janssen Award for Biomedical Research, and Louisa Gross Horwitz Prize.